UroGen Reports Five-Year Olympus Follow-Up Data on JELMYTO
Five-year Olympus follow-up data published in Therapeutic Advances in Urology reinforce durable response with JELMYTO in patients with low-grade upper tract urothelial cancer.
Five-year Olympus follow-up data published in Therapeutic Advances in Urology reinforce durable response with JELMYTO in patients with low-grade upper tract urothelial cancer.